Biocon gets approval for Insulin Glargine

From Mexican health authority, COFEPRIS

Biocon announced that its Insulin Glargine has been approved by COFEPRIS, the Mexican health authority, through its partner PiSA Farmaceutica (PiSA).

Powered by Capital Market - Live News